Yahoo Web Search

  1. Yahoo Finance Results

  2. Analyst David Risinger raised Mylan from Equal-weight to Overweight and increased the price target from $39 to $50. Notably, Mylan is now Morgan Stanley’s only Overweight generic ...

  3. Amgen (AMGN) Gets CHMP Nod to Expand EU Label of Neulasta

    Zacks via Yahoo FinanceMar 01 14:40 PM

    Biotech major Amgen Inc. AMGN announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion to update ...

    40.41-0.39 (-0.96%)

    at Tue, Mar 20, 2018, 15:00PM EST - U.S. Markets open in 46 mins

    Pre Mkt N/A

    Delayed Quote

    • Ask Price 40.41
    • Bid Price 40.00
    • P/E 31.08
    • 52 Wk. High 47.82
    • 52 Wk. Low 29.39
    • Mkt. Cap 20.8B
  4. Mylan shares bounce on plans for Botox copycat, 2018 drug launches

    MarketWatch via Yahoo FinanceMar 02 16:55 PM

    Mylan NV shares surged on Thursday after the company announced plans to bring a lower-priced biosimilar version of the bestselling cosmetic treatment Botox to market. The biosimilar, ...

  5. Mylan beats 4Q profit forecasts

    Associated Press via Yahoo FinanceFeb 28 21:57 PM

    The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.41 per share. The generic drugmaker posted revenue of $3.24 billion in the period, which did ...

  6. Can New Approvals Help Mylan Stock Turn Around in 2018?

    Zacks via Yahoo FinanceMar 09 0:38 AM

    Shares of Mylan N.V. MYL have gained 7.6% in the last three months, as against the industry’s decline of 3.7%. Mylan’s fourth-quarter results were mixed with the bottom line exceeding ...

  7. Steven Cohen Takes Stake in Biotech Company Agenus via Yahoo FinanceMar 07 15:19 PM

    By Sydnee Gatewood Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed this week he established a 6.13% stake in Agenus Inc. AGEN) on Feb. 21. Warning!

  8. Edited Transcript of MYL earnings conference call or presentation 28-Feb-18 10:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMar 01 16:51 PM

    Mylan N.V. - CFO * Melissa Trombetta * Rajiv Malik Mylan N.V. - President & Executive Director ====... Analyst * Elliot Henry Wilbur Raymond James & Associates, Inc., Research ...

  9. Theravance Biopharma (TBPH) Q4 Loss Wider, Sales Drop Y/Y

    Zacks via Yahoo FinanceFeb 28 14:20 PM

    Theravance Biopharma TBPH reported fourth-quarter 2017 loss of $1.64 per share, wider than both the Zacks Consensus Estimate of a loss of $1.15 and the year-ago loss of $1.36. Today, you can download 7 Best Stocks for the Next 30 Days.

  10. Mylan teams up with Revance on biosimilar for Botox

    Reuters via Yahoo FinanceFeb 28 22:36 PM

    Mylan NV on Wednesday struck a licensing agreement with Revance Therapeutics Inc to develop a biosimilar of Allergan Plc's blockbuster Botox wrinkle treatment. The deal includes ...

  11. Want to be a Buy and Hold Investor? 3 Strategies

    Zacks via Yahoo FinanceMar 08 15:26 PM

    Welcome to Episode #84 of the Value Investor Podcast Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio service, shares some of her top value investing tips and stock picks ...

  1. Ads
    related to Mylan Inc